Crispr Therapeutics shares owned by Arkadios Wealth Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Arkadios Wealth Advisors
from 13F filings
Historical chart of Arkadios Wealth Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Arkadios Wealth Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Arkadios Wealth Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $531k | 11k | 46.98 |
| 2024-06-30 | $582k | 11k | 54.01 |
| 2024-03-31 | $741k | 11k | 68.16 |
| 2023-12-31 | $690k | 11k | 62.60 |
| 2023-09-30 | $511k | 11k | 45.39 |
| 2023-06-30 | $625k | 11k | 56.14 |
| 2023-03-31 | $529k | 12k | 45.23 |
| 2022-12-31 | $477k | 12k | 40.65 |
| 2022-09-30 | $852k | 13k | 65.37 |
| 2022-06-30 | $805k | 13k | 60.75 |
| 2022-03-31 | $830k | 13k | 62.76 |
| 2021-12-31 | $971k | 13k | 75.74 |
| 2021-09-30 | $19k | 170 | 111.76 |
| 2021-06-30 | $27k | 170 | 158.82 |
| 2020-12-31 | $5.0k | 34 | 147.06 |
| 2020-09-30 | $2.2k | 20 | 109.80 |
| 2020-06-30 | $1.8k | 20 | 90.90 |
| 2020-03-31 | $848 | 20 | 42.40 |